Search filters

List of works by Gerhard Zugmaier

A novel functional polymorphism in the transforming growth factor-beta2 gene promoter and tumor progression in breast cancer

scientific article published on August 2006

A phase I study of the safety and pharmacokinetics of the combination of pertuzumab (rhuMab 2C4) and capecitabine in patients with advanced solid tumors

scientific article published in May 2008

ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children

scientific article published on 14 February 2019

Adhesion of T Cells to Endothelial Cells Facilitates Blinatumomab-Associated Neurologic Adverse Events

scientific article published on 29 October 2019

Aneuploidy in childhood B cell acute lymphoblastic leukaemia - also a relevant prognostic factor in relapsed disease?

scientific article published on 05 February 2019

Anti-B-Cell Maturation Antigen BiTE Molecule AMG 420 Induces Responses in Multiple Myeloma

scientific article published on 02 January 2020

Anti-CD19 BiTE Blinatumomab Induces High Complete Remission Rate In Adult Patients with Relapsed B-Precursor ALL: Updated Results of An Ongoing Phase II Trial ⬇️

scholarly article

Anti-CD19 BiTE Blinatumomab Induces High Complete Remission Rate and Prolongs Overall Survival in Adult Patients with Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL) ⬇️

scholarly article

Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study

scientific article published on 16 February 2016

Blinatumomab Monotherapy Shows Efficacy in Patients with Relapsed Diffuse Large B Cell Lymphoma ⬇️

scholarly article

Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

scientific article published on 17 April 2019

Blinatumomab for minimal residual disease in adults with B-precursor acute lymphoblastic leukemia

scientific article

Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study

scientific article published on 24 July 2020

Blinatumomab treatment of older adults with relapsed/refractory B-precursor acute lymphoblastic leukemia: Results from 2 phase 2 studies

scientific article published on 3 May 2016

Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia

scientific article published on 24 February 2020

Blinatumomab vs historic standard-of-care treatment for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukaemia

scientific article published on 24 January 2020

Bronchioloalveolar carcinoma: sonographic pattern of 'pneumonia'

scientific article published on 01 October 2002

CD33 target validation and sustained depletion of AML blasts in long-term cultures by the bispecific T-cell-engaging antibody AMG 330.

scientific article published on 3 December 2013

Changes in clinical laboratory parameters and pharmacodynamic markers in response to blinatumomab treatment of patients with relapsed/refractory ALL

scientific article published on 18 May 2017

Clinical overview of anti-CD19 BiTE(®) and ex vivo data from anti-CD33 BiTE(®) as examples for retargeting T cells in hematologic malignancies

scientific article

Color Doppler sonographic mapping of pulmonary lesions: evidence of dual arterial supply by spectral analysis

scientific article published on 01 October 2003

Color Doppler sonographic signs of respiration-dependent hepatofugal portal flow

scientific article published in February 2004

Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia

scientific article published on 03 July 2020

Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy.

scientific article published on 15 May 2013

Day 15 bone marrow minimal residual disease predicts response to blinatumomab in relapsed/refractory paediatric B-ALL

scientific article published on 03 December 2019

Fatal bleeding complications caused by Evans syndrome (autoimmune thrombocytopenia and hemolytic anemia) and type II autoimmune hepatitis in a 56-year-old patient

scientific article

Focal splenic lesions in myeloproliferative disease: association with fatal outcome

scientific article published on 3 October 2003

Harnessing T cells to fight cancer with BiTE® antibody constructs--past developments and future directions

scientific article published on March 2016

Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell–engaging CD19/CD3-bispecific BiTE antibody blinatumomab ⬇️

scientific article published on May 16, 2012

Immunotherapy of lymphoma and leukemia with T-cell engaging BiTE antibody blinatumomab

scientific article

Immunotherapy using bispecific T cell engager (BiTE®) antibodies: preclinical and clinical experience in acute leukemia.

scientific article published on 6 November 2014

Inhibition of HER-2 by three independent targeting strategies increases paclitaxel resistance of SKOV-3 ovarian carcinoma cells

scientific article published on 08 February 2005

Long-Term Outcomes after Blinatumomab Treatment: Follow-up of a Phase 2 Study in Patients (Pts) with Minimal Residual Disease (MRD) Positive B-Cell Precursor Acute Lymphoblastic Leukemia (ALL) ⬇️

scholarly article

Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia

scientific article published on 12 January 2017

Long-term survival and T-cell kinetics in relapsed/refractory ALL patients who achieved MRD response after blinatumomab treatment

scientific article

Long-term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab

scientific article published on 03 November 2020

Minimal residual disease level predicts outcome in adults with Ph-negative B-precursor acute lymphoblastic leukemia

scientific article published on 01 December 2019

Molecular response with blinatumomab in relapsed/refractory B-cell precursor acute lymphoblastic leukemia

scientific article published on 01 October 2019

Open-label phase II study evaluating the efficacy and safety of two doses of pertuzumab in castrate chemotherapy-naive patients with hormone-refractory prostate cancer.

scientific article

Pathogenesis-Based Development of Potential Mitigation Strategies for Blinatumomab-Associated Neurologic Events (NEs) ⬇️

scholarly article

Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab.

scientific article

Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

scientific article

Phase II study of the human anti-epithelial cell adhesion molecule antibody adecatumumab in prostate cancer patients with increasing serum levels of prostate-specific antigen after radical prostatectomy

scientific article published on 02 July 2010

Phase II trial of the anti-CD19 bispecific T cell-engager blinatumomab shows hematologic and molecular remissions in patients with relapsed or refractory B-precursor acute lymphoblastic leukemia

scientific article published on 10 November 2014

Prognostic significance of transforming growth factor beta receptor II in estrogen receptor-negative breast cancer patients

scientific article published on 01 January 2004

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study

scientific article

Significance of heparin-binding growth factor expression on cells of solid pediatric tumors

scientific article published on September 2003

Spontaneous nontraumatic intrasplenic pseudoaneurysm: causes, sonographic diagnosis, and prognosis

scientific article published in March 2003

Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia

scholarly article by Lia Gore et al published 22 August 2018 in Blood Cancer Journal

Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival

scientific article published on 16 May 2011

The small spleen: sonographic patterns of functional hyposplenia or asplenia

scientific article

Tumor regression in cancer patients by very low doses of a T cell-engaging antibody

scientific article

[Antibodies in hematology by the example of acute lymphatic leukemia]

scientific article published on 01 October 2019

Paulina is supported by:

About Paulina

Help